(Reuters) – A federal judge on Wednesday gave final approval to a multimillion-dollar settlement in a lawsuit brought by about 5,000 former National Football League players who accused the league […]

WHIPPANY, N.J., April 22, 2015 /PRNewswire/ — Bayer is pleased to announce today that the U.S. Food and Drug Administration (FDA) has accepted the filing for Bayer’s supplemental Biologics License Application […]

(Reuters) – Swiss drugmaker Roche has “renewed confidence” that drugs targeting potentially brain-destroying plaque can fight Alzheimer’s disease, following promising results with a product from a rival. Pharmaceuticals head Daniel […]

There are very few assurances in life, but in the field of generic pharmaceuticals, there are three certainties we are about to witness: 1. This is now the Spring of […]

(Reuters) – Novo Nordisk has launched its Saxenda obesity drug in the United States, it said on Wednesday, a long-awaited milestone that will provide a new revenue stream for the […]

Pittsburgh, Penn.-based Mylan Inc. (MYL)’s $30 billion unsolicited bid for generic drugmaker Perrigo Company (PRGO) has been rejected by the company, after Perrigo said late Tuesday that the offer “substantially […]